Approval · Notice of Compliance 29416 · 2022
COMIRNATY: Notice of Compliance 29416
Issued October 26, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29416
- Date
- October 26, 2022
- Company
- Biontech Manufacturing GmbhMainz, Rheinland-Pfalz, Germany
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug substance manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMIRNATY | Not yet assigned | — |
Medicinal ingredients
- TOZINAMERAN 30 MCG per DOSE
- TOZINAMERAN 10 MCG per DOSE
- TOZINAMERAN 3 MCG per DOSE
- TOZINAMERAN 30 MCG per 0.3ML